Recital 54, Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

In force

Applicants that have invested in supporting the approval of an active substance or the authorisation of a biocidal product in accordance with this Regulation or Directive 98/8/EC should be able to recover part of their investment by receiving equitable compensation whenever use of proprietary information which they submitted in support of such approval or authorisation is made for the benefit of subsequent applicants.

  • celex=31998R0008
  • num:eu=1998/8